This article reviews the current literature on the efficacy of pharmacologic, dietary and psychosocial interventions for FAP and IBS in children and adolescents. Although most children and ...

Medically reviewed by Qin Rao, MD Irritable bowel syndrome (IBS) is a common digestive disorder that affects the large ...

Aim: To assess the SIBO prevalence and symptoms improvement in IBS children after treatment with Rifaximin. Study design: 43 (mean age 9,5 ys) consecutive children affected by IBS according to ...

Irritable bowel syndrome is the most common cause of chronic diarrhea and lower abdominal discomfort in North America.

Although most children with functional gastrointestinal disorders, such as FAP and IBS, will improve with time and reassurance, a subset of patients may present to the primary care physician or ...